Page 394 - Read Online

Page 10 of 10 Sempokuya et al. Hepatoma Res 2019;5:38 I http://dx.doi.org/10.20517/2394-5079.2019.013

2. White DL, Thrift AP, Kanwal F, Davila J, El-Serag HB. Incidence of hepatocellular carcinoma in all 50 united states, from 2000
through 2012. Gastroenterology 2017;152:812-20.
3. Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, et al. AASLD guidelines for the treatment of hepatocellular carcinoma.
Hepatology 2018;67:358-80.
4. Herrero JI, Sangro B, Pardo F, Quiroga J, Iñarrairaegui M, et al. Liver transplantation in patients with hepatocellular carcinoma across
Milan criteria. Liver Transpl 2008;14:272-8.
5. Altekruse SF, McGlynn KA, Dickie LA, Kleiner DE. Hepatocellular carcinoma confirmation, treatment, and survival in surveillance,
epidemiology, and end results registries, 1992-2008. Hepatology 2012;55:476-82.
6. Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients
with cirrhosis: a meta-analysis. PLoS Med 2014;11:e1001624.
7. Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection: patterns, treatments,
and prognosis. Ann Surg 2015;261:947-55.
8. Fernandez-Sevilla E, Allard MA, Selten J, Golse N, Vibert E, et al. Recurrence of hepatocellular carcinoma after liver transplantation:
is there a place for resection? Liver Transpl 2017;23:440-7.
9. Chagas AL, Felga GEG, Diniz MA, Silva RF, Mattos AA, et al. Hepatocellular carcinoma recurrence after liver transplantation in a
brazilian multicenter study: clinical profile and prognostic factors of survival. Eur J Gastroenterol Hepatol 2019;31:1148.
10. Foerster F, Hoppe-Lotichius M, Vollmar J, Marquardt JU, Weinmann A, et al. Long-term observation of hepatocellular carcinoma
recurrence after liver transplantation at a European transplantation centre. United Eur Gastroenterol J 2019;7:838-49.
11. Zhang JA, Kwee SA, Wong LL. Late recurrence of hepatocellular carcinoma after liver transplantation. Hepatoma Res 2017;3:58-66.
12. Alshahrani AA, Ha SM, Hwang S, Ahn CS, Kim KH, et al. Clinical features and surveillance of very late hepatocellular carcinoma
recurrence after liver transplantation. Ann Transplant 2018;23:659-65.
13. Xu XF, Xing H, Han J, Li ZL, Lau WY, et al. Risk factors, patterns, and outcomes of late recurrence after liver resection for
hepatocellular carcinoma: a multicenter study from china. JAMA Surg 2019;154:209-17.
14. Chen PC, Chiu NC, Su CW, Huang YH, Hou MC, et al. Albumin-bilirubin grade may determine the outcomes of patients with very
early stage hepatocellular carcinoma after radiofrequency ablation therapy. J Chin Med Assoc 2019;82:2-10.
15. Maluccio MA, Zang Y, Pi W, Tann M, Kubal C, et al. Survival in patients with hepatocellular carcinoma (HCC): a report of 1444
patients treated within a multidisciplinary program. J Clin Oncol 2017;35:e15652-e15652.
16. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, et al. A model to predict survival in patients with end-stage liver
disease. Hepatology 2001;33:464-70.
17. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, et al. Development of a simple noninvasive index to predict significant fibrosis
in patients with HIV/HCV coinfection. Hepatology 2006;43:1317-25.
18. Mazzaferro V, Bhoori S, Sposito C, Bongini M, Langer M, et al. Milan criteria in liver transplantation for hepatocellular carcinoma:
an evidence-based analysis of 15 years of experience. Liver Transpl 2011;17:S44-57.
19. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 2013;48:452-8.
20. Hassan I, Gane E. Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those
related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme. Intern Med J 2019.
21. Wu KT, Wang CC, Lu LG, Zhang WD, Zhang F-J, et al. Hepatocellular carcinoma: clinical study of long-term survival and choice of
treatment modalities. World J Gastroenterol 2013;19:3649-57.
22. Zheng J, Kuk D, Gönen M, Balachandran VP, Kingham TP, et al. Actual 10-year survivors after resection of hepatocellular carcinoma.
Ann Surg Oncol 2017;24:1358-66.
23. Chapman BC, Paniccia A, Hosokawa PW, Henderson WG, Overbey DM, et al. Impact of facility type and surgical volume on 10-year
survival in patients undergoing hepatic resection for hepatocellular carcinoma. J Am Coll Surg 2017;224:362-72.
24. Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and
prognostic factors. Am J Gastroenterol 2012;107:569-77.
25. Lee K, Lee KB, Yi NJ, Suh KS, Jang JJ. Prognosis of hepatocellular carcinoma after liver transplantation: comparative analysis with
partial hepatectomy. J Pathol Transl Med 2017;51:79-86.